Skip to main content
Harbin Pharmaceutical Group Co.,Ltd. logo

Harbin Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 600664 ISIN · CNE0000009T3 LEI · 300300G0L086UJ23MI26 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,827 across all filing types
Latest filing 2020-10-23 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 600664

About Harbin Pharmaceutical Group Co.,Ltd.

https://www.hayao.com/

Harbin Pharmaceutical Group Co., Ltd. specializes in the research, development, manufacture, and distribution of a diverse range of pharmaceutical and healthcare products. The company's portfolio includes antibiotics, over-the-counter (OTC) medicines, health supplements, traditional Chinese medicines, and animal health products. It operates through several specialized subsidiaries and maintains a significant presence in the production of penicillins and cephalosporins. A key strategic focus involves the health and nutrition sector, bolstered by the acquisition of global nutrition brand GNC. The company leverages large-scale manufacturing capabilities and an extensive distribution network to serve both domestic and international markets. Its operations emphasize technological innovation and quality control across its integrated supply chain, from raw material production to finished dosage forms.

Recent filings

Filing Released Lang Actions
哈药集团股份有限公司八届三十六次董事会关于聘任证券事务代表的决议公告
Board/Management Information Classification · 100% confidence The document is an announcement from the board of directors of 哈药集团股份有限公司 regarding the appointment of a securities affairs representative. It details the board meeting, voting results, and the appointee's background and contact information. There is no financial data, no report or presentation content, and no mention of financial results or regulatory filings beyond the appointment. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management roles.
2020-10-23 Chinese
哈药集团股份有限公司关于公司证券事务代表辞职的公告
Board/Management Information Classification · 95% confidence The document is a short announcement regarding the resignation of the company's securities affairs representative. It does not contain financial data, report content, or detailed management information. It is an announcement about a change in a company representative related to securities affairs, which falls under management or board-related information. Given the nature of the announcement about a personnel change, the most appropriate classification is Board/Management Information (MANG). The document length is very short and it is not a report or financial statement.
2020-10-23 Chinese
哈药集团股份有限公司关于董事会及监事会延期换届的提示性公告
Board/Management Information Classification · 95% confidence The document is a short announcement from 哈药集团股份有限公司 regarding the postponement of the board of directors and supervisory board re-election. It contains no financial data, no detailed report, and is clearly an announcement about board/management changes. The content focuses on governance and management continuity, which fits the category of Board/Management Information (MANG). The document length is short and it is not a report or financial statement, so it is not an Annual Report or Interim Report. Therefore, the classification is MANG with high confidence.
2020-10-23 Chinese
哈药集团股份有限公司关于GNC相关事宜的进展公告
Regulatory Filings Classification · 95% confidence The document is an announcement from 哈药集团股份有限公司 regarding the progress of matters related to GNC, specifically about a court hearing and the impact on the company's convertible preferred shares and net assets. It provides updates on financial impacts and references previous disclosures but does not contain full financial statements or comprehensive financial data. The document is relatively short (708 characters) and serves as a progress update or regulatory announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-10-16 Chinese
2020年第一次临时股东大会之法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the procedural legality and validity of a company's 2020 first extraordinary general meeting (临时股东大会). It details the convening, attendance, voting procedures, and results of the meeting, confirming compliance with laws and company articles. It does not contain financial statements or detailed financial performance data, nor is it a report of financial results or management discussion. It is a legal opinion related to a shareholder meeting, specifically focusing on the legality of the meeting and voting process. This type of document is best classified under Regulatory Filings (RNS) as it is a compliance/legal procedural document rather than a financial report or announcement of voting results (which would be DVA). The document length is under 5,000 characters and it is a standalone legal opinion letter, not a report publication announcement or certification. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2020-09-28 Chinese
2020年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 2020 first extraordinary general meeting of shareholders of 哈药集团股份有限公司. It details the meeting date, attendance, voting results, and legal witness statements. It does not contain financial statements or detailed financial analysis, but rather the official voting results and procedural compliance information. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short and focused on voting outcomes, not a full report or presentation.
2020-09-28 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.